VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma (VICTORY)
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:
• Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
• No current vitamin D intake above the recommended 400 IU/day
• No endocrine-, heart-, kidney- or auto-immune disorders
Locations
Other Locations
Denmark
Copenhagen University Hospital of Copenhagen
RECRUITING
Gentofte
Contact Information
Primary
Klaus Bønnelykke, PhD
kb@copsac.com
+4538677360
Backup
Ulrik Ralfkiaer, PhD
administration@dbac.dk
+4538674164
Time Frame
Start Date: 2024-12-20
Estimated Completion Date: 2033-03
Participants
Target number of participants: 2000
Treatments
Experimental: Vitamin D3 (cholecalciferol) 3200 IU/day
Oral intake of 1 capsule daily from week 22-26 of gestation until 1 week after delivery
Placebo_comparator: Placebo Pearls with olive oil
Oral intake of 1 capsule daily from week 22-26 of gestation until 1 week after delivery
Related Therapeutic Areas
Sponsors
Leads: Professor Klaus Bønnelykke